[Ultra-high dosage lysis of deep venous thrombosis in ipsipedal administration along with compression].
The ipsipedal application of UHSK leads to a decisive increase of recanalisation. The fibrinolyticum will be brought in a greater quantity to the thrombotic region. The adjuvant supramalleolar compression and the increase of volume seems to be beneficial. The promising results of thrombolysis at elder thrombosis justify a late fibrinolysis, which is profitable too, for patients with early postoperative thrombosis at the end of the first wound healing phase.
Dembinski
W
W
Radiologie, Marien-Hospitals Witten.
Kohl
C
C
Geisbüsch
R
R
Rickels
L
L
Neitzel
J R
JR
Loncarevic
F
F
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001458:Bandages; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013300:Streptokinase / Q000008:administration & dosage*; D013924:Thrombophlebitis / Q000628:therapy*
D013300:Streptokinase
UHSK-Lyse tiefer Venenthrombosen bei ipsipedaler Applikation unter Kompressionsbedingungen.